Nature Biotechnology Q1 Unclaimed
Nature Biotechnology is a monthly journal covering the science and business of biotechnology. It publishes new concepts in technology/methodology of relevance to the biological, biomedical, agricultural and environmental sciences as well as covers the commercial, political, ethical, legal, and societal aspects of this research. The first function is fulfilled by the peer-reviewed research section, the second by the expository efforts in the front of the journal. It has an SJR impact factor of 18,117.
Nature Biotechnology focuses its scope in these topics and keywords: protein, virus, plant, antibody, transgenic, stem, gene, control, biotech, tobacco, ...
Type: Journal
Type of Copyright:
Languages: English
Open Access Policy: Open Choice
Type of publications:
Publication frecuency: -
9500 €
Inmediate OANPD
Embargoed OA0 €
Non OAMetrics
18,117
SJR Impact factor511
H Index485
Total Docs (Last Year)1066
Total Docs (3 years)13393
Total Refs17008
Total Cites (3 years)461
Citable Docs (3 years)13.24
Cites/Doc (2 years)27.61
Ref/DocOther journals with similar parameters
Nature Microbiology Q1
Nature Biomedical Engineering Q1
Protein & Cell Q1
PLoS Medicine Q1
Nano Today Q1
Compare this journals
Aims and Scope
Best articles by citations
On the road to therapeutic cloning
View moreFlies in the soup - European GM labeling legislation
View moreUS to safeguard 'dual-use' biology research
View moreProtecting careers, not lives
View moreEncoding human serine phosphopeptides in bacteria for proteome-wide identification of phosphorylation-dependent interactions
View moreAuthor Correction: Template plasmid integration in germline genome-edited cattle
View moreAuthor Correction: Using GlycoDelete to produce proteins lacking plant-specific N-glycan modification in seeds
View moreCooperativity of Esterases and Xylanases in the Enzymatic Degradation of Acetyl Xylan
View moreThe insects are coming
View moreToo little, too late: when is the right time for new leadership in biotech?
View moreTo recruit the best R&D professionals, understand what drives them
View moreErratum: Corrigendum: Phenotypic alteration of eukaryotic cells using randomized libraries of artificial transcription factors
View mored-(L-a-Aminoadipyl)-L-Cysteinyl-D-Valine Synthetase, the Multienzyme Integrating the Four Primary Reactions in beta-Lactam Biosynthesis, as a Model Peptide Synthetase
View moreErratum: Corrigendum: Visualization of tumors and metastases in live animals with bacteria and vaccinia virus encoding light-emitting proteins
View moreUnshackling expression profiling arrays
View moreHuman Proteinpedia enables sharing of human protein data
View moreLessons from Eprex for biogeneric firms
View moreEither/or selection markers for plant transformation
View moreGenomics companies shop around for chemical expertise
View moreJournalism with a worldview
View moreMcClellan moves on, sets sights on drug reimbursement
View morePhage diabody repertoires for selection of large numbers of bispecific antibody fragments
View moreRogan steps down as USPTO director
View morePredicting antidepressant response by electroencephalography
View more
Comments